KENYA has approved Russia’s Sputnik V vaccine for use against the new coronavirus, Russia’s RDIF sovereign wealth fund said on Wednesday.
The fund, which is promoting the vaccine globally, said that 47 countries had now approved Sputnik V for use.
Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

KENYA has approved Russia’s Sputnik V vaccine for use against the new coronavirus, Russia’s RDIF sovereign wealth fund said on Wednesday.
The fund, which is promoting the vaccine globally, said that 47 countries had now approved Sputnik V for use.
